NERA Economic Consulting
ENTIRE SITE
NERA EXPERTS
EXPERTS
PRACTICE AREAS
ABOUT NERA |
Contact Us
About NERA
MMC Family
GLOBAL LOCATIONS |
CASE & PROJECT EXPERIENCE |
PUBLICATIONS |
Just Published
Newsletters & Briefs
Publications Search
EVENTS & NEWS |
Events
Speakers' Bureau
Continuing Legal Education
Press Releases
NERA in the News
Media Kit
CAREERS
Home
>
Practice Areas
>
Pharmaceutical Industry
> View All
|
More
< Go Back
All Publications for Pharmaceutical Industry
What Is Your Patent Case Worth: Economic Principles of Intellectual Property Damages Calculations
Report
1999-10-06
By Dr. Phillip Beutel
The Costs to the US Health Care System of Extending Marketing Exclusivity for Taxol
Published Article
1999-09-01
By Dr. Richard Rozek
The TRIPS Agreement and Access to Health Care
Published Article
1999-09-01
By Dr. Richard Rozek with Nicola Tully
Modern Methods For the Valuation of Intellectual Property
Report
1998-11-01
By Drs. Richard Rapp and Lauren Stiroh
A Note on the Law & Economics of Acceptable Non-Infringing Alternatives
Brief
1998-10-01
By Dr. Phillip Beutel
Regulatory Influences on the Decision to Introduce Pharmaceutical Products in Japan
Published Article
1998-09-01
By Dr. Richard Rapp and Dr. Richard Rozek with Gakushuin University Professor of Economics Tshuruhiko Nambu
The Effects of Patent Protection on the Prices of Pharmaceutical Products - Is IP Protection Raising the Drug Bill in Developing Countries?
Published Article
1998-03-01
By Dr. Richard Rozek
Finding Patent Litigation Strategies That Make Economic Sense: What Does Your Client Really Need?
Brief
1998-01-01
By Dr. Phillip Beutel
Applying the Best Method Rule When Reliable Internal Comparable Intangibles Exist
Published Article
1996-04-08
By Dr. Richard Rozek
A Note on Price-Cost Tests for Predation: How Do Start-Up Ventures Affect the Price-Cost Test?
Working Paper
1994-09-01
By Dr. Phillip Beutel
< Back
1
2
3
Next >